Clinical trial
Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis
NCT00100607 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00100607 |
|---|---|
| Title | Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis |
| Official title | Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | AAE581 |
| Enrollment | 676 |
| Start date | Feb 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Jan 4, 2005 |
| Last update posted | May 8, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: